Who makes [12C] RO7049389?

[12C] RO7049389 is developed by Hoffmann-La Roche.

What are the side effects of [12C] RO7049389?

Common side effects include Infusion related reaction, Headache, Eyelid rash, Abdominal pain, Aphthous ulcer, Nausea.

Last reviewed 2026-04-20 · How we verify

[12C] RO7049389

Hoffmann-La Roche · Phase 1 active Small molecule Quality 5/100

At a glance

Generic name	[12C] RO7049389
Sponsor	Hoffmann-La Roche
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

Infusion related reaction
Headache
Eyelid rash
Abdominal pain
Aphthous ulcer
Nausea
Vomiting
Catheter site pain
Incorrect dose administered
Dermatitis
Rash
Back pain

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

[12C] RO7049389 CI brief — competitive landscape report
[12C] RO7049389 updates RSS · CI watch RSS
Hoffmann-La Roche portfolio CI